Available Forms: Tablets / Oral suspension
Available Strengths: 400 mg, 600 mg, 600mg/5ml
Reference Brands: Felbatol (USA)
Category: Neurology
Felbamate is an antiepileptic drug used to control partial seizures and Lennox-Gastaut syndrome when other treatments are not effective. It works by modulating GABA receptors and inhibiting NMDA receptors in the brain. Felbamate is generally reserved for patients unresponsive to other therapies due to the risk of serious adverse effects such as aplastic anemia and hepatic failure. It is available as tablets and oral suspension under the brand names Felbatol and Taloxa.
Quick Response Guaranteed | Verified Suppliers
Felbamate is used to treat certain types of seizures in patients with epilepsy. It is particularly effective in controlling partial seizures and seizures associated with Lennox-Gastaut syndrome, a severe form of childhood-onset epilepsy. Felbamate is generally prescribed when other antiepileptic medications have not provided adequate seizure control.
Felbamate is made from the active ingredient felbamate, a dicarbamate derivative chemically known as 2-phenyl-1,3-propanediol dicarbamate. It works by modulating the activity of neurotransmitters in the brain, primarily by inhibiting excitatory neurotransmission mediated by NMDA receptors and enhancing the inhibitory effects of GABA.
The trade name of felbamate is Felbatol, which is primarily used in the United States.
Felbamate (Felbatol) is manufactured by Meda Pharmaceuticals, a part of Mylan N.V. (now Viatris). Several generic versions are also available through different pharmaceutical manufacturers.
The generic name of the drug is felbamate.
The main brand name of felbamate is Felbatol. Some regions may also market it under local generic brands depending on the manufacturer.
Felbamate is manufactured in the United States by Meda Pharmaceuticals and also produced by other generic manufacturers in countries such as India and the European Union for export and local supply.
Strength: 125 mg/mL, 200 mg, 250 mg, 300 mg, 500 mg, 100 mg/mL
Form: Tablet / Capsule/ Injection / Oral syrup
Reference Brands: Depakene (USA), Depakine (EU/LATAM), Valprol (India)
Strength: 50 mg, 100 mg
Form: Tablets
Reference Brands: Ubrelvy (USA/India)
Strength: 100 mg
Reference Brands: Tasmar (USA/EU)
Strength: 50 mg ,100 mg
Reference Brands: Xadago (USA/EU)
By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under βFair use.β
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Stay updated on pharma trends and marketplace opportunities.
Online Β· B2B Pharma Β· Medical Tourism Β· NPP